Bulis Veronica Sanchez sold $9K of LYEL
Bulis Veronica Sanchez (VP, Corporate Controller) sold 621 shares of Lyell Immunopharma, Inc. (LYEL) at $14.34 on 2026-08-10.
How this was made
The 30-second read
Why it matters
The disclosure updates the record of insider selling activity but does not introduce new company fundamentals or forward-looking guidance.
Market read
Traders may note insider selling, but there is no new operational or financial catalyst in the text.
What to watch
The filing states no pre-arranged 10b5-1 plan, but it does not provide intent, liquidity needs, or whether other insiders are buying/selling.
Background
The article is a SEC Form 4 insider transaction disclosure for Lyell Immunopharma, Inc.
Ticker impact
Lyell Immunopharma disclosed a Form 4 showing VP Corporate Controller Bulis Veronica Sanchez sold 621 shares at $14.34 on 2026-08-10.
Low likelihood of a sustained price move based solely on this Form 4 sale.
The filing is an insider transaction (not a guidance, trial, deal, or regulatory event) and the disclosed sale size is modest relative to typical company market caps.
Market effects
No clear sector read-through from a single insider sale.
None indicated.
None indicated.
Counterpoint
Insider sales can be driven by diversification or taxes, so the signal may be weaker than traders assume.
Key entities
- issuerLyell Immunopharma, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderBulis Veronica Sanchez
VP, Corporate Controller who sold 621 shares.